Short-term effect of bezafibrate on the expression of adiponectin mRNA in the adipose tissues: A study in spontaneously type 2 diabetic rats with visceral obesity

Endocrine

Volumn 25, Issue 3, 2004, Pages 247-251

  Mori, Yutaka ^a   Oana, Fumiki ^b   Matsuzawa, Akane ^b   Akahane, Satoshi ^b   Tajima, Naoko ^c  

^a Kawachi gun   (Japan)

^b KISSEI PHARMACEUTICAL CO LTD   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adiponectin; Bezafibrate; Hypertriglyceridemia; OLETF rats

Indexed keywords

ADIPONECTIN; BEZAFIBRATE; CHYLOMICRON; FATTY ACID; INSULIN; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; TRIACYLGLYCEROL; ANTILIPEMIC AGENT; SIGNAL PEPTIDE; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FATTY ACID BLOOD LEVEL; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; GENETICS; GLUCOSE BLOOD LEVEL; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OTSUKA LONG EVANS TOKUSHIMA FATTY RAT;

ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; ANTILIPEMIC AGENTS; BEZAFIBRATE; BLOOD GLUCOSE; CHOLESTEROL, VLDL; CHYLOMICRONS; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; OBESITY; RATS; RATS, INBRED OLETF; RNA, MESSENGER;

EID: 22244433844     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1385/ENDO:25:3:247     Document Type: Article

References (20)

1. Weyer, C., Funahashi, T., Tanaka, S., et al. (2001). J. Clin. Endocrinol. Metab. 86, 1930-1935.
2. Yamamoto, Y., Hirose, H., Saito, I., et al. (2002). Clin. Sci. 103, 137-142.
3. Hotta, K., Funahashi, T., Arita, Y., et al. (2000). Arterioscler. Thromb. Vasc. Biol. 20, 1595-1599.
4. Schoonjans, K., Staels, B., and Auwerx, J. (1996). Biochim. Biophys. Acta 1302, 93-109.
5. Inoue, I., Noji, S., Shen, M. Z., Takahashi, K., and Katayama, S. (1997). Biochem. Biophys. Res. Commun. 237, 606-619.
6. Matsui, H., Okumura, K., Kawakami, K., Hibino, M., Toki, H., and Ito, T. (1997). Diabetes 46, 348-353.
7. Inoue, I., Takahashi, K., Katayama, S., et al. (1994). Diabetes Res. Clin. Pract. 25, 199-205.
8. Jones, I. R., Swai, A., Taylor, R., Miller, M., Laker, M. F., and Alberti, K. G. (1990). Diabetes Care 13, 855-863.
9. Tenenbaum, A., Motro, M., Fisman, E. Z., et al. (2004). Circulation 109, 2197-2202.
10. Hikita, M., Bujo, H., Yamazaki, K., et al. (2000). Biochem. Biophys. Res. Commun. 277, 423-429.
11. Totsuka, M., Miyashita, Y., Ito, Y., Watanabe, H., Murano, T., and Shirai, K. (2000). Atherosclerosis 153, 175-179.
12. Maeda, N., Takahashi, M., Funahashi, T., et al. (2001). Diabetes 50, 2094-2099.
13. Iwaki, M., Matsuda, M., Maeda H., et al. (2003). Diabetes 52, 1655-1663.
14. Inoue, I., Itoh, F., Aoyagi, S., et al. (2002). Biochem. Biophys. Res. Commun. 290, 131-139.
15. Möhlig, M., Wegewitz, U., Osterhoff, M., et al. (2002). Horm. Matab. Res. 34, 655-658.
16. Jovinge, S., Hamsten, A., Tornvall, P., et al. (1998). Metabolism 47, 113-118.
17. Mohrschladt, M. F., Weverling-Rijnsburger, A. W. F., de Man, F. H. A. F., et al. (2002). Atherosclerosis 148, 413-419.
18. Mori, Y., Komiya, H., Kurokawa, N., et al. (2003). Jikeikai Med. J. 50, 75-83.
19. Sato, T., Asahi, Y., Toide, K., and Nakayama, N. (1995). Diabetologia 38, 1033-1041.
20. Kawano, K., Hirashima, T., Mori, S., Saitoh, Y., Kurosumi, M., and Natori, T. (1992). Diabetes 41, 1422-1428.